0001209191-20-029926.txt : 20200518
0001209191-20-029926.hdr.sgml : 20200518
20200518082612
ACCESSION NUMBER: 0001209191-20-029926
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200518
DATE AS OF CHANGE: 20200518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Salzmann Peter
CENTRAL INDEX KEY: 0001796309
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38906
FILM NUMBER: 20888115
MAIL ADDRESS:
STREET 1: 320 W 37TH STREET, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunovant, Inc.
CENTRAL INDEX KEY: 0001764013
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832771572
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 917-580-3099
MAIL ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp
DATE OF NAME CHANGE: 20190108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-15
0
0001764013
Immunovant, Inc.
IMVT
0001796309
Salzmann Peter
320 W 37TH STREET, 3RD FLOOR
NEW YORK
NY
10018
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
19.01
2020-05-15
4
A
0
430700
0.00
A
2030-05-14
Common Stock
430700
430700
D
25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
/s/ W. Bradford Middlekauff, attorney-in-fact for Peter Salzmann
2020-05-18